"Le Centre Hospitalier Universitaire de la Guadeloupe (CHUG) est le pilier sanitaire de l'archipel. Il assure les missions de soins, de prévention, d'enseignement et de recherche confiées par l'État. Au-delà de ces missions, il joue un rôle prépondérant d’hôpital de proximité pour son bassin de population et participe à des actions de santé publique (éducation pour la santé et prévention). Le CHUG est composé de 8 pôles médicaux regroupant 44 services répartis sur 3 sites : - Le centre hospitalier principal appelé nouveau centre (NCH) ou hôpital général - L’hôpital Joseph Ricou appelé ancien hôpital - Le site de Palais-Royal qui accueil le Pôle Parents-Enfants (PPE) et le Pôle Évaluation Réadaptation et Suivi des Incapacités (ERSI)."

During the past decade, CHU Pointe-à-Pitre conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHU Pointe-à-Pitre" #1 sponsor was "Centre Hospitalier Departemental Vendee" with 4 trials, followed by "Centre Hospitalier Universitaire de Pointe-a-Pitre" with 3 trials sponsored, "Institut National de la Santé Et de la Recherche Médicale, France" with 3 trials sponsored, "ADDMEDICA SASA" with 2 trials sponsored and "ANRS, Emerging Infectious Diseases" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHU Pointe-à-Pitre" #1 collaborator was "University Hospital, Tours" with 5 trials as a collaborator, "Ministry of Health, France" with 4 trials as a collaborator, "Centre Hospitalier Universitaire de Pointe-a-Pitre" with 2 trials as a collaborator, "Nantes University Hospital" with 2 trials as a collaborator and "Poitiers University Hospital" with 2 trials as a collaborator. Other collaborators include 52 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "CHU Pointe-à-Pitre" are "Ventilator-associated Pneumonia" (3 trials), "HIV Infections" (2 trials), "Prostate Cancer" (2 trials), "Sickle Cell Disease" (2 trials) and "Adnexal Tumor of Skin" (1 trials). Many other conditions were trialed in "CHU Pointe-à-Pitre" in a lesser frequency.

Most popular intervention types in "CHU Pointe-à-Pitre" are "Procedure" (6 trials), "Drug" (5 trials), "Device" (4 trials), "Other" (4 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "Endotracheal tubes allowing SSD" (3 trials), "Endotracheal tubes not allowing SSD" (3 trials), "ANS activity" (1 trials), "Blood sample" (1 trials) and "Delayed strategy" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHU Pointe-à-Pitre" are 25 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "CHU Pointe-à-Pitre". 1 are not yet recruiting, 8 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in CHU Pointe-à-Pitre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHU Pointe-à-Pitre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 12 trials that are defined as “Not Applicable".